CLINICAL CHARACTERISTICS OF STATIN MANAGEMENT IN A COHORT WITH CARDIOVASCULAR RISK IN COLOMBIA

被引:0
|
作者
Aldana, V [1 ]
Vera, C. C. [1 ]
Jimenez, A. [1 ]
Horta, P. [1 ]
Carrasquilla, M. [2 ]
Salcedo Mejia, F. [2 ]
Alvis Zakzuk, N. J. [3 ]
Moyano, L. [2 ]
Londono, S. [4 ]
Moreno, J. P. [4 ]
Botero, L. [4 ]
机构
[1] Inst Cardiovasc Tolima, Ibague, Colombia
[2] ALZAK Fdn, Cartagena, Colombia
[3] Univ Costa, Bogota, Colombia
[4] Sanofi, Bogota, Colombia
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
CO188
引用
收藏
页码:S50 / S50
页数:1
相关论文
共 50 条
  • [31] Statin discontinuation and risk of cardiovascular events in older people: A population-based cohort study in Denmark
    Thompson, Wade
    Morin, Lucas
    Jarbol, Dorte Ejg
    Andersen, Jacob
    Ernst, Martin
    Nielsen, Jesper B.
    Haastrup, Peter
    Schmidt, Morten
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 77 - 77
  • [32] Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: A nationwide population-based cohort study
    Hung, Chen-Ying
    Lin, Ching-Heng
    Wang, Kuo-Yang
    Huang, Jin-Long
    Hsieh, Yu-Cheng
    Loh, El-Wui
    Lan, Tsuo-Hung
    Chou, Pesus
    Ting, Chih-Tai
    Wu, Tsu-Juey
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1131 - 1136
  • [33] Floods Risk Management in Colombia
    Gueiza Suarez, Leonardo
    LETRAS VERDES, 2012, (12): : 25 - 41
  • [34] Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use
    Huang, Qing
    Grabner, Michael
    Sanchez, Robert J.
    Willey, Vincent J.
    Cziraky, Mark J.
    Palli, Swetha R.
    Power, Thomas P.
    AMERICAN HEALTH AND DRUG BENEFITS, 2016, 9 (08): : 434 - 444
  • [35] EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN THE REDUCTION OF PREMATURE MORTALITY ASSOCIATED TO CARDIOVASCULAR EVENTS IN THE CARIBBEAN REGION OF COLOMBIA
    Miranda, P. A.
    Salcedo Mejia, F. E.
    Parra Padilla, D.
    Vargas, R.
    Paz-Wilches, J.
    Fernandez Mercado, J. C.
    Alvis Zakzuk, J.
    Alvis Zakzuk, N.
    Alvis-Guzman, N.
    De La Hoz, F.
    VALUE IN HEALTH, 2019, 22 : S119 - S119
  • [36] Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study
    Aboud, M.
    Elgalib, A.
    Pomeroy, L.
    Panayiotakopoulos, G.
    Skopelitis, E.
    Kulasegaram, R.
    Dimian, C.
    Lampe, F. C.
    Duncan, A.
    Wierzbicki, A. S.
    Peters, B. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (09) : 1252 - 1259
  • [37] IMPACT OF DISEASE MANAGEMENT PROGRAM "DE TODO CORAZON" OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIA
    Paz, J. J.
    Granados, C. E.
    Morales, C.
    Rodriguez, N.
    Buitrago, L. A.
    Guete, A.
    Caceres, H. A.
    Ramirez, P.
    Pardo, R.
    VALUE IN HEALTH, 2011, 14 (03) : A46 - A47
  • [38] STATIN-INDUCED MYOPATHY: DIFFERENT STRATEGIES FOR MANAGEMENT AND DIFFICULT CHALLENGES TO REDUCE CARDIOVASCULAR RISK
    De Flaviis, C.
    D'Ardes, D.
    Pierdomenico, A. M.
    Bellisario, I.
    Tiberio, F.
    La Scorciosa, C.
    Pierdomenico, M.
    Dell'Acqua, A.
    Di Monte, D.
    Caradio, F.
    Rossi, I.
    Cipollone, F.
    Bucci, M.
    ATHEROSCLEROSIS, 2019, 287 : E202 - E202
  • [39] CLINICAL EFFECTIVENESS AND COST-ANALYSIS OF NEW ORAL ANTIDIABETICS IN A COHORT OF TYPE 2 DIABETIC PATIENTS FROM A CARDIOVASCULAR RISK PROGRAM IN COLOMBIA
    Echeverri, E.
    Ruiz, A. J.
    Rondon, M.
    Echeverri, S.
    Rosselli, D.
    VALUE IN HEALTH, 2023, 26 (06) : S51 - S51
  • [40] Clinical characteristics and management of acute cholecystitis after cardiovascular surgery
    Yasukawa, Koya
    Shimizu, Akira
    Kubota, Koji
    Notake, Tsuyoshi
    Sugenoya, Shinsuke
    Hosoda, Kiyotaka
    Hayashi, Hikaru
    Kobayashi, Ryoichiro
    Soejima, Yuji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (02) : 211 - 220